Lung and bronchial system (Neoplasia NSCLC)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung and bronchial system (Neoplasia NSCLC).php on line 2
Lung and bronchial system (Neoplasia NSCLC)

LE WE PMID CA

Lung and bronchial system (Neoplasia NSCLC)

12117

Lunge und Bronchialsystem (Neubildung NSCLC)

ALK Anaplastic lymphoma kinase

BRCA1

Crizotinib ttALK

EML4

Gefitinib ttEGFR

Gemcitabine

HDAC1

Lung and bronchial system (Neoplasia NSCLC)

Maspin

Neoplasia (Tumor biology and immunology)

Receptor (EGF)

RNA (MicroRNA)

Tumor suppressor

2010 1	The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. [20337574] Curr Pharm Des 16(16): 1877-81 (2010)
2005 2	Molecular pathology of non-small-cell lung cancer. [15942304] Respiration 72(3): 313-30 (2005)
2010 3	Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). [19915840] Eur J Nucl Med Mol Imaging 37(4): 691-8 (2010)
2011 4	Customizing systemic therapy in patients with advanced non-small cell lung cancer. [21904581] Ther Adv Med Oncol 3(4): 207-18 (2011)
2011 5	Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer. [21904578] Ther Adv Med Oncol 3(4): 163-70 (2011)
2011 6	Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. [21904576] Ther Adv Med Oncol 3(3): 127-38 (2011)
2011 7	The potential for crizotinib in non-small cell lung cancer: a perspective review. [22084642] Ther Adv Med Oncol 3(6): 279-91 (2011)
2010 8	Advanced non-small cell lung cancer: the role of maintenance therapy. [21789123] Ther Adv Med Oncol 2(1): 17-23 (2010)
2011 9	Review of the treatment of metastatic non small cell lung carcinoma: A practical approach. [21773076] World J Clin Oncol 2(6): 262-71 (2011)
2011 10	Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma. [21273174] Clin Lung Cancer 12(1): 14-7 (2011)
2008 11	BRCA1: a new genomic marker for non-small-cell lung cancer. [19073515] Clin Lung Cancer 9(6): 331-9 (2008)
2009 12	Second-line therapy for non-small-cell lung cancer. [19362951] Clin Lung Cancer 10(2): 91-8 (2009)
2009 13	Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making. [19443333] Clin Lung Cancer 10(3): 148-50 (2009)
2009 14	Advanced non-small-cell lung cancer in the elderly. [19443335] Clin Lung Cancer 10(3): 158-67 (2009)
2009 15	Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer. [19289365] Clin Lung Cancer 10(1): 8-9 (2009)
2011 16	Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer. [21695043] Clin Med Insights Oncol 5(-): 177-84 (2011)
2010 17	The biology and treatment of EML4-ALK non-small cell lung cancer. [20418096] Eur J Cancer 46(10): 1773-80 (2010)
2010 18	The tumor microenvironment in non-small-cell lung cancer. [20685578] Semin Radiat Oncol 20(3): 156-63 (2010)
2009 19	Overview of gefitinib in non-small cell lung cancer: an Asian perspective. [19088154] Jpn J Clin Oncol 39(3): 137-50 (2009)
2011 20	Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer. [21469981] Cancer Invest 29(4): 325-37 (2011)
2011 21	Use of epidermal growth factor receptor mutation analysis in patients with advanced non-small-cell lung cancer to determine erlotinib use as first-line therapy. [21743846] PLoS Curr 3(-): RRN1245 (2011)
2007 22	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. [17610986] Lung Cancer 58(1): 95-103 (2007)
2011 23	Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. [21767219] Clin Chem Lab Med 49(10): 1591-603 (2011)
2007 24	Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer. [17158592] J Med Genet 44(3): 166-72 (2007)
2011 25	Maintenance therapy in NSCLC: why? To whom? Which agent? [21548925] J Exp Clin Cancer Res 30(-): 50 (2011)
PMC 26	Docetaxel and Cisplatin regimen for non-small-cell lung cancer. [24421519] Hosp Pharm 48(7):550-7 (2013)
PMC 27	Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. [24409356] J Thorac Dis 5(6):783-9 (2013)
PMC 28	Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. [24409352] J Thorac Dis 5(6):758-63 (2013)
PMC 29	Pertuzumab and erlotinib in patients with relapsed non-small cell lung cancer: a phase II study using 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. [24457379] Oncologist 19(2):175-6 (2014)
PMC 30	Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea. [23401441] J Clin Oncol 31(8):1009-20 (2013)
PMC 31	Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (Review). [24649011] Biomed Rep 1(5):691-696 (2013)
PMC 32	Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation. [24649213] Mol Clin Oncol 1(4):575-581 (2013)
PMC 33	Lobectomy vs. segmentectomy for NSCLC (T<2 cm). [24790839] Ann Cardiothorac Surg 3(2):160-6 (2014)
PMC 34	Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer. [24790836] Ann Cardiothorac Surg 3(2):134-41 (2014)
PMC 35	gene overexpression in non-small-cell lung cancer. [24748981] Biomed Rep 2(3):392-395 (2014)
PMC 36	Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC. [24688780] J Thorac Dis 6(4):356-68 (2014)
PMC 37	Accelerated dose escalation with proton beam therapy for non-small cell lung cancer. [24688779] J Thorac Dis 6(4):348-55 (2014)
PMC 38	Radiation dose effect in locally advanced non-small cell lung cancer. [24688778] J Thorac Dis 6(4):336-47 (2014)
PMC 39	Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer. [24688777] J Thorac Dis 6(4):328-35 (2014)
PMC 40	Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer. [24688773] J Thorac Dis 6(4):285-6 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung and bronchial system (Neoplasia NSCLC).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lung and bronchial system (Neoplasia NSCLC).php on line 92